Anamorelin vs BPC-157
Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz. versus The recovery king; speeds up tendon, muscle, and gut healing for faster training turnarounds.
Anamorelin
PerformanceOral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Top benefits
- ✓Increases lean body mass
- ✓Improves appetite
- ✓Oral bioavailability
BPC-157
RecoveryThe recovery king; speeds up tendon, muscle, and gut healing for faster training turnarounds.
Top benefits
- ✓Speeds up tendon healing
- ✓Accelerates muscle recovery
- ✓Promotes gut healing
- ✓Reduces inflammation
| Attribute | Anamorelin | BPC-157 |
|---|---|---|
| Category | Performance | Recovery |
| Type | small-molecule | linear |
| Chain length | 1 aa | 15 aa |
| Formula | C31H42N6O3 | C62H98N16O22 |
| Common dose | 100 mg | 250-500 mcg |
| Frequency | Daily, oral | Twice daily (AM/PM) |
| Top benefit | Increases lean body mass | Speeds up tendon healing |
| Top side-effect | Hyperglycemia | Minimal reported side effects |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.